Patents by Inventor Davide De Forni

Davide De Forni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity
    Patent number: 10294218
    Abstract: Novel 4,6-disubstituted aminopyrimidine derivatives with the following structure (I) have anti-HIV activity.
    Type: Grant
    Filed: February 25, 2017
    Date of Patent: May 21, 2019
    Assignee: VIROSTATICS SRL
    Inventors: Franco Lori, James Chafouleas, Davide De Forni, Antonio Solinas, Zoltán Varga, Zoltán Greff, László Õrfi, György Kéri
  • NOVEL 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES HAVE ANTI-HIV ACTIVITY
    Publication number: 20170204084
    Abstract: Novel 4,6-disubstituted aminopyrimidine derivatives with the following structure (I) have anti-HIV activity.
    Type: Application
    Filed: February 25, 2017
    Publication date: July 20, 2017
    Applicant: VIROSTATICS SRL
    Inventors: Franco Lori, James Chafouleas, Davide De Forni, Antonio Solinas, Zoltán Varga, Zoltán Greff, László Õrfi, György Kéri
  • 4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity
    Patent number: 9617225
    Abstract: Novel 4,6-disubstituted aminopyrimidine derivatives with the following structure (I) have anti-HIV activity.
    Type: Grant
    Filed: August 23, 2013
    Date of Patent: April 11, 2017
    Assignee: VIROSTATICS SRL
    Inventors: Franco Lori, James Chafouleas, Davide De Forni, Antonio Solinas, Zoltán Varga, Zoltán Greff, László Örfi, György Kéri
  • NOVEL 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES HAVING BOTH AROMATIC AND HALOGENIC SUBSTITUENTS
    Publication number: 20140057911
    Abstract: Certain 4,6-disubstituted aminopyrimidine derivatives having both aromatic and halogenic substituents.
    Type: Application
    Filed: August 23, 2013
    Publication date: February 27, 2014
    Inventors: Franco Lori, James Chafouleas, Davide De Forni, Antonio Solinas, Zoltán Varga, Zoltán Greff, László Örfi, György Kéri
  • Anti-proliferative substituted pyrazolo[3,4-d]pyrimidines derivatives (SPP) to inhibit immune activation, virus replication and tumor growth
    Publication number: 20120022048
    Abstract: A family of pyrazolo[3,4-d]pyrimidine derivatives (SPPs) with different substituents on the pyrimidine and pyrazolo rings have been characterized with a panel of tests demonstrating their effects in cell proliferation, toxicity, apoptosis and inhibition of virus replication. We have identified compounds and molecular structures suitable for the treatment of viral infection because they have antiviral activity, anti-proliferative activity or, preferably, both so that, as a single molecule, they both limit T cell hyperactivation and inhibit virus replication. These compounds are not toxic at effective concentrations and are poorly apoptotic. Other nontoxic compounds within this family with excellent anti-proliferative and apoptotic features are potentially effective as anti-cancer drugs.
    Type: Application
    Filed: July 22, 2010
    Publication date: January 26, 2012
    Inventors: Franco Lori, Davide De Forni, Michael Ray Stevens